Apyx Medical Corporation (APYX)Healthcare | Medical Devices | Clearwater, United States | NasdaqGS
3.08 USD
+0.08
(2.667%)
⇧
(Aug. 28, 2026, 4 p.m.
EDT)
After hours: 3.12 +0.04 (1.299%) ⇧ (Aug. 28, 2026, 7:30 p.m. EDT) |
Hot Take ↕ | Aug. 22, 2026, 5:31 a.m. EDT
The investment case for Apyx Medical is severely compromised by deteriorating fundamentals and a broken price trend. Despite a recent year-over-year recovery in share price, the company has suffered a catastrophic 71.6% decline over the last six years, with four of those years seeing negative returns. This multi-year structural decline suggests the market has permanently downgraded its view of the business, regardless of recent operational improvements or analyst upgrades. The financial health is precarious, characterized by negative free cash flow, negative operating margins, and a debt-to-equity ratio exceeding 350%, indicating significant leverage relative to shareholder equity. Furthermore, the complete absence of a dividend program eliminates any income floor for investors. While the stock trades at a low P/S ratio, this reflects the reality of a struggling micro-cap rather than a deep value opportunity. Options data confirms this pessimism, with heavy put positioning signaling that speculators expect further weakness. The combination of a failing balance sheet, a long-term downtrend, and lack of cash returns warrants a strong avoidance stance. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.102313 |
| AutoETS | 0.102332 |
| MSTL | 0.108336 |
| AutoTheta | 0.126614 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 29% |
| H-stat | 13.31 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.038 |
| Excess Kurtosis | -0.68 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 357.349 |
| Revenue per Share | 1.37 |
| Market Cap | 129,741,992 |
| Forward P/E | -11.94 |
| Beta | 1.35 |
| Profit Margins | -14.78% |
| Website | https://apyxmedical.com |
As of Aug. 22, 2026, 5:31 a.m. EDT: Speculators are positioning heavily for downside protection with significant open interest in out-of-the-money puts expiring in late 2027, while call activity remains sparse and concentrated at lower strikes. The implied volatility for puts is notably elevated compared to calls, suggesting a market consensus that the stock faces further pressure rather than a catalyst for a rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.5625 |
| Address1 | 5,115 Ulmerton Road |
| All Time High | 17.5 |
| All Time Low | 0.755 |
| Ask | 3.89 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 175,340 |
| Average Daily Volume3 Month | 133,229 |
| Average Volume | 133,229 |
| Average Volume10Days | 175,340 |
| Beta | 1.351 |
| Bid | 2.24 |
| Bid Size | 2 |
| Book Value | 0.253 |
| City | Clearwater |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 3.08 |
| Current Ratio | 5.683 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,786,665,600 |
| Day High | 3.22 |
| Day Low | 3.0 |
| Debt To Equity | 357.349 |
| Display Name | Apyx Medical |
| Earnings Call Timestamp End | 1,786,048,200 |
| Earnings Call Timestamp Start | 1,786,048,200 |
| Earnings Timestamp | 1,786,046,400 |
| Earnings Timestamp End | 1,793,908,800 |
| Earnings Timestamp Start | 1,793,908,800 |
| Ebitda | -2,755,000 |
| Ebitda Margins | -0.04716 |
| Enterprise To Ebitda | -51.609 |
| Enterprise To Revenue | 2.434 |
| Enterprise Value | 142,181,984 |
| Eps Current Year | -0.272 |
| Eps Forward | -0.258 |
| Eps Trailing Twelve Months | -0.21 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 3.8864 |
| Fifty Day Average Change | -0.80640006 |
| Fifty Day Average Change Percent | -0.20749281 |
| Fifty Two Week Change Percent | 56.25 |
| Fifty Two Week High | 5.08 |
| Fifty Two Week High Change | -2.0 |
| Fifty Two Week High Change Percent | -0.39370078 |
| Fifty Two Week Low | 1.7 |
| Fifty Two Week Low Change | 1.3799999 |
| Fifty Two Week Low Change Percent | 0.8117646 |
| Fifty Two Week Range | 1.7 - 5.08 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,546,439,400,000 |
| Float Shares | 30,496,108 |
| Forward Eps | -0.258 |
| Forward P E | -11.937984 |
| Free Cashflow | -9,631,625 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 205 |
| Fullday Change | 0.0799999 |
| Fullday Change Percent | 2.66666 |
| Fullday Price | 3.12 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.63496 |
| Gross Profits | 37,091,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.13545999 |
| Held Percent Institutions | 0.50588 |
| Implied Shares Outstanding | 42,124,023 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Apyx Medical Corporation, an energy technology company, designs, develops, manufactures, and sells electrosurgical equipment and medical devices in the United States and internationally. The company operates through two segments: Surgical Aesthetics and Original Equipment Manufacturing (OEM). It offers helium plasma generator for the delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures; and a portfolio of single-use handpieces and accessories for open and laparoscopic procedures. The company's helium plasma technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida. |
| Long Name | Apyx Medical Corporation |
| Market | us_market |
| Market Cap | 129,741,992 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_250771 |
| Most Recent Quarter | 1,782,777,600 |
| Net Income To Common | -8,634,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 126,372,069 |
| Number Of Analyst Opinions | 5 |
| Open | 3.0 |
| Operating Cashflow | -10,128,000 |
| Operating Margins | -0.13008 |
| Payout Ratio | 0.0 |
| Peg Ratio | 0.59 |
| Phone | 727 384 2323 |
| Post Market Change | 0.03999996 |
| Post Market Change Percent | 1.2987001 |
| Post Market Price | 3.12 |
| Post Market Time | 1,787,959,805 |
| Previous Close | 3.0 |
| Price Eps Current Year | -11.323528 |
| Price Hint | 4 |
| Price To Book | 12.173913 |
| Price To Sales Trailing12 Months | 2.221039 |
| Profit Margins | -0.1478 |
| Quick Ratio | 4.408 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.0799999 |
| Regular Market Change Percent | 2.66666 |
| Regular Market Day High | 3.22 |
| Regular Market Day Low | 3.0 |
| Regular Market Day Range | 3.0 - 3.22 |
| Regular Market Open | 3.0 |
| Regular Market Previous Close | 3.0 |
| Regular Market Price | 3.08 |
| Regular Market Time | 1,787,947,201 |
| Regular Market Volume | 114,843 |
| Return On Assets | -0.03708 |
| Return On Equity | -0.90693 |
| Revenue Growth | 0.221 |
| Revenue Per Share | 1.37 |
| Sand P52 Week Change | 0.20504117 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 42,124,023 |
| Shares Percent Shares Out | 0.0055 |
| Shares Short | 230,354 |
| Shares Short Previous Month Date | 1,784,073,600 |
| Shares Short Prior Month | 251,668 |
| Short Name | Apyx Medical Corporation |
| Short Percent Of Float | 0.0058 |
| Short Ratio | 2.3 |
| Source Interval | 15 |
| State | FL |
| Symbol | APYX |
| Target High Price | 8.0 |
| Target Low Price | 6.0 |
| Target Mean Price | 6.6 |
| Target Median Price | 6.0 |
| Total Cash | 27,617,000 |
| Total Cash Per Share | 0.656 |
| Total Debt | 39,630,000 |
| Total Revenue | 58,415,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -0.21 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 3.844425 |
| Two Hundred Day Average Change | -0.76442504 |
| Two Hundred Day Average Change Percent | -0.19883989 |
| Type Disp | Equity |
| Volume | 114,843 |
| Website | https://apyxmedical.com |
| Zip | 33,760-4004 |